Product Overview
Recombinant SARS Associated Coronavirus M Protein immunodominant region. Not full-length M protein. Contains GST fusion partner, was expressed in E. coli. Immunoreactive with SARS positive sera.
Purity
> 95% pure (10% PAGE, coomassie staining). GS-4B Sepharose-Affinity Purification
Concentration
1 mg/ml (Bradford method)
Buffer
50mM Tris-HCl, pH 8.0, 60mM NaCl containing 50% glycerol
Storage
2-8°C short term, -20°C long term
Introduction
A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive stranded RNA approximately 27 to 31kb in length.
Keywords
Matrix glycoprotein; CoV M
Citations
Have you cited DAG497 in a publication?
Let us know and earn a reward for your research.
| Product Name |
Cat. No. |
Applications |
Host Species |
Datasheet |
Price |
Add to Basket |
| Product Name |
Cat. No. |
Applications |
Host Species |
Datasheet |
Price |
Add to Basket |
Tripet, B; Kao, DJ; et al. Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus. JOURNAL OF STRUCTURAL BIOLOGY 155:176-194(2006).
Okada, M; Takemoto, Y; et al. Development of vaccines and passive immunotherapy against SARS coronavirus using mouse and SCID-PBL/hu mouse models. NIDOVIRUSES: TOWARD CONTROL OF SARS AND OTHER NIDOVIRUS DISEASES 581:561-566(2006).
COA
Certificate of Analysis
